Klinischer Stellenwert und Indikationen zur Magnetresonanztomografie des Herzens 2013: Ein interdisziplinäres Expertenstatement

Zusammenfassung

Obwohl in den letzten Jahren wissenschaftlich weitere Indikationen für die Magnetresonanztomografie (MRT) des Herzens erarbeitet wurden, hat sich die Akzeptanz dieser Untersuchungstechnik in Klinik und Praxis bei den Kardiologen und Radiologen nicht mit der gleichen Geschwindigkeit entwickelt wie die diagnostischen Möglichkeiten. Verantwortlich dafür sind unter anderem die notwendige kostspielige Ausstattung, die relativ lange Untersuchungszeit, das hohe Maß an technischem Wissen und nicht zuletzt die fehlende oder unzureichende Remuneration. Darüber hinaus sind ein Festhalten an traditionellen Abklärungsalgorithmen, ein limitierter Zugang zu dieser Technologie sowie Probleme in der fächerübergreifenden Kooperation zu beobachten. Die seit vielen Jahren bestehende interdisziplinäre Kooperation hat die Aufgabe, einen substanziellen Beitrag zur Überwindung der genannten Problemfelder zu leisten und die MRT des Herzens in das Abklärungsspektrum kardialer Erkrankungen als fixen Bestandteil zu integrieren. Eine kontinuierliche Verbesserung der Behandlung von Patienten mittels kosteneffizienter Diagnostik und Therapie hat hierbei höchste Priorität. Die MRT des Herzens spielt dabei eine bedeutende Rolle.

Abstract

During the last years the indications of Cardiac Magnetic Resonance Imaging (CMRI) have been continuously expanded. However, the acceptance of the method by cardiologists and radiologists does not correlate with respect to the diagnostic potential. Several factors, such as expensive equipment, relatively long examination times, high technical know how and lack of remuneration, limit the application of CMRI in everyday clinical practice. Furthermore, doctors tend to apply more conventional, well established diagnostic procedures, the access to the method is still limited and there exist difficulties in the interdisciplinary collaboration. The interdisciplinary Austrian approach to Cardiac Imaging is aimed to improve the aforementioned problems and to support the implementation of CMRI in the diagnostic tree of cardiac diseases thus enabling a cost efficient management of patients in cardiology.

Key words

cardiac - MR-imaging - heart

• Literatur

• 1 Achenbach S, Barkhausen J, Beer M et al. Konsensusempfehlungen der DRG/DGK/DGPK zum Einsatz der Herzbildgebung mit Computertomografie und Magnetresonanztomografie. Fortschr Röntgenstr 2012; 184: 345-368
• 2 Hergan K, Globits S, Loewe C et al. Aktueller Stellenwert der MSCTA in der Koronargefassdiagnostik (2011): Klinischer Leitfaden der Osterreichischen Gesellschaften fur Kardiologie und Radiologie. Fortschr Röntgenstr 2011; 183: 964-971
• 3 Lotz J, Kivelitz D, Fischbach R et al. Empfehlungen für den Einsatz der Computertomografie und Magnetresonanztomografie in der Herzdiagnostik. Teil 2 – Magnetresonanztomografie. Fortschr Röntgenstr 2009; 181: 800-814
• 4 Pennell DJ, Sechtem UP, Higgins CB et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004; 25: 1940-1965
• 5 de Jong MC, Genders TSS, van Geuns RJ et al. Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systemic review and meta-analysis. Eur Radiol (electronically published)
• 6 Nandalur KR, Dwamena BA, Choudhri AF et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease. J Am Coll Cardiol 2007; 50: 1343-1353
• 7 Schwitter J, Wacker CM, Wilke N et al. MR-IMPACT II: Magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J 2012; (first published online March 4, 2012)
• 8 Greenwood JP, Maredia N, Younger JF et al. Cardiovascular magnetic resonance imaging and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARK): a prospective trial. Lancet 2012; 379: 453-460
• 9 Watkins S, McGeoch R, Lyne J et al. Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease. Circulation 2009; 120: 2207-2213
• 10 Chung SY, Lee KY, Chun EJ et al. Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven threevessel coronary artery disease. Am J Roentgenol 2010; 195: 356-362
• 11 Klug G, Mayr A, Schenk S et al. Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012; 14: 46
• 12 Grothues F, Smith GC, Moon JC et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90: 29-34
• 13 Cerqueira MD, Weissman NJ, Dilsizian V et al. Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart: A Statement for Healthcare Proffessionals From the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542
• 14 Allman KC, Shaw LJ, Hachamovitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39: 1151-1158
• 15 Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453
• 16 Wellnhofer E, Olariu A, Klein C et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 2004; 109: 2172-2174
• 17 Kim RJ, Manning WJ. Viability assessment by delayed enhancement cardiovascular magnetic resonance imaging: will low-dose dobutamine dull the shine?. Circulation 2004; 109: 2476-2479
• 18 White JA, Yee R, Yuan X et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006; 48: 1953-1960
• 19 Chalil S, Foley P, Muyhaldeen S et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace 2007; 9: 1031-1037
• 20 Maron BJ, Towbin JA, Thiene G et al. Contemporary definitions and classification of the cardiomyopathies. A scientific statement of the American Heart Association. Circulation 2006; 113: 1807-1816
• 21 Karamitsos TD, Francis JM, Myerson S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol 2009; 54: 1407-1424
• 22 Nathan M, Chia YL, Croisille P et al. Assessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2011; 57: 891-903
• 23 Leyva F. Cardiac resynchronization therapy guided by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010; 12: 64-86
• 24 Leyva F, Foley PW, Chalil S et al. Cardiac resynchronisation therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2011; 13: 29-38
• 25 Pankuweit S, Richter A, Ruppert V et al. Classification of cardiomyopathies and indication for endomyocardial biopsy revisited. Herz 2009; 34: 55-62
• 26 Elliott P, Andersson B, Arbustini E et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008; 29: 270-276
• 27 McCrohon JA, Moon JC, Prasad SK et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance. Circulation 2003; 108: 54-59
• 28 Gersh BJ, Maron BJ, Bonow RO et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: 2703-2738
• 29 White JA, Fine NM, Gula L et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging 2012; 5: 12-20
• 30 Jenni R, Oechslin E, Schneider J et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular noncompaction: a step towards classification as a distinct cardiomyopathy. Heart 2001; 86: 666-671
• 31 Petersen SE, Selvanayagam JB, Wiesmann F. Left Ventricular Non-Compaction: Insights From Cardiovascular Magnetic Resonance Imaging. J Am Coll Cardiol 2005; 46: 101-105
• 32 Dursun M, Agayev A, Ertugrul T et al. MR imaging features of ventricular noncompaction: Emphasis on distribution and pattern of fibrosis. Eur J Radiol 2010; 74: 147-151
• 33 Fernández-Pérez GC, Anguilar-Arjona JA, Tardáguilla de la Fuente G et al. Takotsubo cardiomyopathy: Assessment with cardiac MRI. Am J Roentgenol 2010; 195: W139-W145
• 34 Sharkey SW, Windenburg DC, Lesser JR et al. Natural History and Expansive Clinical Profile of Stress (Tako-Tsubo) Cardiomyopathy. J Am Coll Cardiol 2010; 55: 333-341
• 35 Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992; 182: 369-373
• 36 Mahrholdt H, Wagner A, Judd RM et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005; 26: 1461-1474
• 37 Cheng H, Zhao S, Jiang S et al. The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy. J Cardiovasc Magn Reson 2011; 13: 15-23
• 38 Breuckmann F, Maderwald S, Buhr C et al. Cardiac MRI: estimation of changes in normalized myocardial gadolinium accumulation over time after contrast injection in patients with acute myocarditis and healthy volunteers. Fortschr Röntgenstr 2011; 183: 933-938
• 39 Friedrich MG, Sechtem U, Schulz-Menger J et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J Am Coll Cardiol 2009; 53: 1475-1487
• 40 Frank H, Globits S. Magnetic Resonance Imaging evaluation of myocardial and pericardial disease. JMRI 1999; 10: 617-626
• 41 Laissy JP, Hyafil F, Juliard JM et al. Differentiating acute myocardial infarction from Myocarditis: Diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 2005; 237: 75-82
• 42 Goitein O, Matetzky S, Beinart R et al. Acute myocarditis: non-invasive evaluation with cardiac MRI and transthoracic echocardiography. Am J Roentgenol 2008; 192: 254-258
• 43 Gahide G, Bertrand D, Roubille F et al. MR delayed enhancement imaging findings in suspected acute myocarditis. Eur Radiol 2010; 20: 65-72
• 44 Gutberlet M, Spors B, Thoma T et al. Suspected chronic myocarditis at cardiac CT: diagnostic accuracy and association with immunohistological detected inflammation and viral persistence. Radiology 2008; 246: 401-409
• 45 Yilmaz A, Kindermann I, Kindermann M et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation 2010; 122: 900-909
• 46 Mahrhold H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109: 1250-1258
• 47 Keller D, Osswald S, Bremerich J. Arrhythmogenic rightventricular dysplasia: diagnostic and prognostic value of cardiac MRI in relation to arrhythmia free survival. Int J Card Imaging 2003; 19: 537-543
• 48 Kayser HW, van der Wall EE, Sivananthan MU et al. Diagnosis of arrhythmogenic right ventricular dysplasie: a review. Radiographics 2002; 22: 639-648
• 49 Marcus FI, Zareba W, Calkins H et al. Arrhytmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm 2009; 6: 984-992
• 50 Bluemke DA, Krupinski EA, Ovitt T et al. MRI Imaging of arrhythmogenic right ventricular cardiomyopathy: morphological findings and intraobserver reliability. Cardiology 2003; 99: 153-612
• 51 Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010; 121: 1533-1541
• 52 Globits S, Kreiner G, Frank H et al. Significance of morphological abnormalities detected by MRI in patients undergoing successful ablation of right ventricular outflow tract tachycardia. Circulation 1997; 96: 2633-2640
• 53 Wang ZJ, Reddy GP, Gotway MB et al. CT and MR imaging of pericardial disease. Radiographics 2003; 23: S167-S180
• 54 Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992; 182: 369-373
• 55 Sechtem U, Tscholakoff D, Higgins CB. MRI of the abnormal pericardium. Am J Roentgenol 1986; 147: 239-244
• 56 Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med 1993; 117: 1027-1031
• 57 Hoffmann U, Globits S, Schima W et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol 2003; 92: 890-895
• 58 Aurigemma G, Reichek N, Schiebler M et al. Evaluation of aortic regurgitation by cardiac cine MRI: planar analysis and comparison to Doppler echocardiography. Cardiology 1991; 78: 340-347
• 59 Wagner S, Auffermann W, Buser P et al. Diagnostic accuracy and estimation of the severity of valvular regurgitation from the signal void on cine magnetic resonance imaging. Am Heart J 1989; 118: 760-767
• 60 Glockner JF, Johnston DL, McGee KP. Evaluation of cardiac valvular disease with MR imaging: Qualitative and quantitative techniques. Radiographics 2003; 23: e9
• 61 Nishimura F. Oblique cine MRI for the evaluation of aortic regurgitation: comparison with cineangiography. Clin Cardiol 1992; 15: 73-78
• 62 Globits S, Frank F, Mayr H et al. Quantitative assessment of aortic regurgitation by magnetic resonance imaging. Eur Heart J 1992 13: 78-83
• 63 Sondergaard L, Lindvig K, Hildebrandt P et al. Quantification of aortic regurgitation by magnetic resonance velocity mapping. Am Heart J 1993; 125: 1081-1090
• 64 Fujita N, Chazouilleres AF, Hartiala JJ et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol 1994; 23: 951-958
• 65 Morris MF, Maleszewski JJ, Suri RM et al. CT and MR imaging of the mitral valve: radiologic-pathologic correlation. Radiographics 2010; 30: 603-620
• 66 Didier D. Assessment of valve disease. Qualitative and quantitative. Magn Reson Imaging Clin N Am 2003; 11: 115-134
• 67 Health Canada. Congenital Anomalies in Canada – A Perinatal Health Report.  Minister of Public Works and Government Services Canada; 2002 http://www.phac-aspc.gc.ca/publicat/cac-acc02/index-eng.php
• 68 Marelli AJ, Mackie AS, Ionescu-Ittu R et al. Congenital heart disease in the general population: Changing prevalence and age distribution. Circulation 2007; 115: 163-172 
• 69 Freeman LJ. Grown up congenital heart (GUCH) disease: a half century of change. Clinical medicine 2008; 8: 169-171 
• 70 Kilner PJ, Geva T, Kaemmerer H et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. European Heart J 2010; 3: 794-805
• 71 Kersting-Sommerhoff BA, Diethelm L, Stanger P et al. Evaluation of complex congenital ventricular anomalies with magnetic resonance imaging. Am Heart J 1990; 120: 133-142
• 72 Hundley WG, Li HF, Lange RA et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oximetric and indicator dilution techniques. Circulation 1995; 91: 2955-2960
• 73 Rebergen SA, Chin JG, Ottenkamp J et al. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation 1993; 92: 1123-1132
• 74 Sommer T, Fehske W, Holzknecht N et al. Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology 1996; 199: 347-352
• 75 Fayad ZA, Nahar T, Fallon JT et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation 2000; 101: 2503-2509
• 76 Steffens JC, Bourne MW, Sakuma H et al. Quantification of collateral blood flow in coarctation of the aorta by velocity encoded cine magnetic resonance imaging. Circulation 1994; 90: 937-943
• 77 Wieben O, Francois C, Reeder SB. Cardiac MRI of ischemic heart disease at 3 T: potential and challenges. Eur J Radiol 2008; 65: 15-28
• 78 Oshinski JN, Delfino JG, Sharma P et al. Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson 2010; 12: 55-68
• 79 Schär M, Kozerke S, Fischer SE et al. Cardiac SSFP imaging at 3 Tesla. Magn Reson Med 2004; 51: 799-806
• 80 Greiser A, Weber O, Deshpande V et al. Improved cardiac shimming in a clinical setting by multi-frame fieldmap acquisition and automatic ROI extension. J Cardiovasc Magn Reson 2007; 9: 239-240
• 81 Wansapura J, Fleck R, Crotty E et al. Frequency scouting for cardiac imaging with SSFP at 3 Tesla. Pediatr Radiol 2006; 36: 1082-1085
• 82 Michaely HJ, Nael K, Schoenberg SO et al. Analysis of cardiac function – comparison between 1.5 Tesla and 3.0 Tesla cardiac cine magnetic resonance imaging: preliminary experience. Invest Radiol 2006; 41: 133-140
• 83 Hudsmith LE, Cheng AS, Tyler DJ et al. Assessment of left atrial volumes at 1.5 Tesla and 3 Tesla using FLASH and SSFP cine imaging. J Cardiovasc Magn Reson 2007; 9: 673-679
• 84 Maroules CD, McColl R, Khera A et al. Interstudy reproducibility of SSFP cine magnetic resonance: impact of magnetic field strength and parallel imaging. J Magn Reson Imaging 2008; 27: 1139-1145
• 85 Cheng AS, Pegg TJ, Karamitsos TD et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: a comparison with 1. 5-Tesla. J Am Coll Cardiol 2007; 49: 2440-2449
• 86 Hamon M, Fau G, Née G et al. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 2010; 12: 29-39
• 87 Levine GN, Gomes AS, Arai AE et al. American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Radiology and Intervention. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007; 116: 2878-2891
• 88 Strach K, Naehle CP, Mühlsteffen A et al. Low field magnetic resonance imaging: increased safety for pacemaker patients?. Europace 2009; 12: 952-960
• 89 Naehle CP, Kreuz J, Strach K et al. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibillators at 1.5T. Am Heart J 2011; 161: 1096-1105
• 90 Rouguin A, Schwitter J, Vahlhaus C et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008; 10: 336-346
• 91 Sutton R, Kanal E, Wilkoff BL et al. Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRISureScan pacing system: clinical study design. Trials 2008; 9: 68-76
• 92 Shellock FG. Reference Manual for Magnetic Resonance Safety, Implants, and Devices 2011. Los Angeles: Biomedical Research Publishing Group.